Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study

Bandini Marco; Pompe Raisa S.; Marchioni Michele; Zaffuto Emanuele; Gandaglia Giorgio; Fossati Nicola; Cindolo Luca; Montorsi Francesco; Briganti Alberto; Saad Fred; Karakiewicz Pierre I.

首页> 外文期刊>International Urology and Nephrology >Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study

【24h】

Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study

机译：在当代转移性前列腺癌患者中改善癌症特异性自由存活和总体自由生存：一项基于人群的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Over the past decade, several systemic agents as docetaxel, cabazitaxel, sipuleucel-T, abiraterone and enzalutamide have improved overall survival (OS) in metastatic prostate cancer (mPCa) patients. However, to date the OS benefit was not demonstrated in population-based analysis.

机译：在过去的十年中，几种全身性药物作为多西紫杉醇，卡基茨，西普卢克鲁，ABIRATERONE和苯甲丁酰胺在转移性前列腺癌（MPCA）患者中具有改善的整体存活（OS）。但是，迄今为止，在基于人口的分析中未表明操作系统效益。

著录项

来源
《International Urology and Nephrology》 |2018年第1期|共8页
作者
Bandini Marco; Pompe Raisa S.; Marchioni Michele; Zaffuto Emanuele; Gandaglia Giorgio; Fossati Nicola; Cindolo Luca; Montorsi Francesco; Briganti Alberto; Saad Fred; Karakiewicz Pierre I.;
展开▼
作者单位

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

Univ Med Ctr Hamburg Eppendorf Martini Klin Hamburg Germany;

Univ G dAnnunzio SS Annunziata Hosp Dept Urol Chieti Italy;

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

ASL Abruzzo 2 Dept Urol Chieti Italy;

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

IRCCS Osped San Raffaele URI Div Oncol Unit Urol Via Olgettina 60 I-20132 Milan MI Italy;

Univ Montreal Ctr Hlth Canc Prognost &

Hlth Outcomes Unit Montreal PQ Canada;

Univ Montreal Ctr Hlth Canc Prognost &

Hlth Outcomes Unit Montreal PQ Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Metastatic prostate cancer; Castration-resistant prostate cancer; Systemic agents; Adjuvant therapy; SEER Program; Urology;

机译：转移性前列腺癌;抗阉割前列腺癌;全身性药剂;佐剂治疗;SEER计划;泌尿外科;

相似文献

外文文献
中文文献
专利

1. Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study [J] . Bandini Marco, Pompe Raisa S., Marchioni Michele, International Urology and Nephrology . 2018,第1期

机译：在当代转移性前列腺癌患者中改善癌症特异性自由存活和总体自由生存：一项基于人群的研究
2. Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival, but not Recurrence-Free Survival, in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma [J] . Miyake H., Tei H., Fujisawa M. Current urology. . 2016,第1期

机译：老年营养风险指数是接受非转移性肾细胞癌手术切除的患者特定癌症生存率的重要预测指标，但并非无复发生存率的重要指标
3. Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival, but not Recurrence-Free Survival, in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma [J] . Hideaki Miyake, Hiromoto Tei, Masato Fujisawa Current urology. . 2016,第1期

机译：老年人营养风险指数是癌症特异性生存的重要预测因子，但没有复发存活，在接受非转移性肾细胞癌外科手术切除的患者中
4. Label-Free, Magnetic Nanocarrier based, Precisian Combinatorial Chemotherapeutics Treatment Against Metastatic Cancer for Recurrence-Free Survival [C] . Juliane Hopf, Margo Waters, Paul Helquist, Society for Biomaterials annual meeting and exposition . 2019

机译：基于标记的磁性纳米载体的Precisian组合化学疗法可治疗转移癌，无复发生存率。
5. Clinically Significant Prostate Cancer: Biological and Epidemiological Observations to Improve Cancer-Free and Survival Metrics. [D] . Wallis, Christopher J.D. 2017

机译：具有临床意义的前列腺癌：改善无癌和生存指标的生物学和流行病学观察。
6. Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival but not Recurrence-Free Survival in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma [O] . Hideaki Miyake, Hiromoto Tei, Masato Fujisawa 2017

机译：老年营养风险指数是非转移性肾细胞癌手术切除患者癌症特异性生存率的重要预测指标而非无复发生存率的重要指标
7. Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival [O] . Daniel M. Lim, Roman Gulati, Serge Aleshin-Guendel, 2018

机译：在生物化学上复发患者的短期症状抗剥皮治疗后未检测到的前列腺特异性抗原与无转移存活和前列腺癌特异性生存相关

Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study

摘要

著录项

相似文献

相关主题

期刊订阅